Ginsburg, G. S., Lekstrom-Himes, J., & Trepicchio, W. (2006). Optimizing biomarker development for clinical studies at the lead optimization stage of drug development. In R. T. Borchardt, E. H. Kerns, M. J. Hageman, D. R. Thakker, & J. L. Stevens (Eds.), OPTIMIZING THE DRUG-LIKE PROPERTIES OF LEADS IN DRUG DISCOVERY (Vol. 4, pp. 411-+). Parsippany, NJ: SPRINGER.

Ginsburg, Geoffrey S., Julie Lekstrom-Himes, and William Trepicchio. “Optimizing biomarker development for clinical studies at the lead optimization stage of drug development.” In OPTIMIZING THE DRUG-LIKE PROPERTIES OF LEADS IN DRUG DISCOVERY, edited by R. T. Borchardt, E. H. Kerns, M. J. Hageman, D. R. Thakker, and J. L. Stevens, 4:411-+. SPRINGER, 2006.

Ginsburg GS, Lekstrom-Himes J, Trepicchio W. Optimizing biomarker development for clinical studies at the lead optimization stage of drug development. In: Borchardt RT, Kerns EH, Hageman MJ, Thakker DR, Stevens JL, editors. OPTIMIZING THE DRUG-LIKE PROPERTIES OF LEADS IN DRUG DISCOVERY. SPRINGER; 2006. p. 411-+.

Ginsburg, Geoffrey S., et al. “Optimizing biomarker development for clinical studies at the lead optimization stage of drug development.” OPTIMIZING THE DRUG-LIKE PROPERTIES OF LEADS IN DRUG DISCOVERY, edited by R. T. Borchardt et al., vol. 4, SPRINGER, 2006, pp. 411-+.

Ginsburg GS, Lekstrom-Himes J, Trepicchio W. Optimizing biomarker development for clinical studies at the lead optimization stage of drug development. In: Borchardt RT, Kerns EH, Hageman MJ, Thakker DR, Stevens JL, editors. OPTIMIZING THE DRUG-LIKE PROPERTIES OF LEADS IN DRUG DISCOVERY. SPRINGER; 2006. p. 411-+.